HomeWebcastPharmaceutical Brand Protection Program: Latest Trends and Legal Considerations Demystified!
Pharmaceutical Brand Protection Program CLE CLE

Pharmaceutical Brand Protection Program: Latest Trends and Legal Considerations Demystified!

Live Webcast Date: Thursday, July 09, 2015 from 3:00 pm to 5:00 pm (ET)
Healthcare CLE & CPERecording

Pharmaceutical Brand Protection Program CLE

Join us for this Knowledge Group Pharmaceutical Brand Protection Program CLE Webinar. The pharmaceutical industry is changing dramatically and rapidly with the introduction worldwide of new regulations, advances in technology, and greater competition. As a result, pharmaceutical firms want to decrease risk, and increase efficiency, transparency, and collaboration in the supply chain.

Numerous methods are used to protect pharmaceutical brands. Pharmaceutical companies increasingly use investigators to protect their supply chains and fight counterfeiting. The recent addition of the Food and Drug Agency’s Track and Trace obligations increases the need for brand owners to consider protecting brands and their distribution.  Other tactics include serialization to combat the circulation of counterfeit drugs, and use of bar codes, RFIDs, Holograms, Taggants, and other anti-counterfeiting devices and methods.

While Canada has a number of similarities to the US regulatory regime, it also differs in many respects, including regarding regulatory exclusivities available and the patent linkage scheme.  Further, Health Canada has new requirements directed to brand name assessments that will in most cases require assessments independent from those conducted for the US.

In this two-hour Webcast, a panel of distinguished professionals and thought leaders assembled by The Knowledge Group will discuss Pharmaceutical Brand Protection Programs and provide the audience with an overview of the Latest Trends and Legal Considerations in protecting pharmaceutical brands. Speakers will also offer best practices in developing and implementing an effective Pharmaceutical Brand Protection Program.

Key topics include:

  • Brand Protection in the Pharmaceutical Industry
    • Branding basics: Drug Names
    • Overview of the Trademark Process for Drug Names at the USPTO
    • Overview of the Regulatory Process for Drug Names at the FDA
    • Best Practices in Drug Naming
  • Update some recent decisions on induced infringement aspect
  • Other recent decisions
  • Update state of the law
  • Canada: Data protection and possible future patent term restoration
  • Patented Medicines (Notice of Compliance) Regulations (listing, litigation)
  • Regulatory process for drug names in Canada

Agenda

Segment 1:
Karen Won, Attorney
Cooley LLP

  • Branding basics: Drug Names
  • Overview of the Trademark Process for Drug Names at the USPTO
  • Overview of the Regulatory Process for Drug Names at the FDA
  • Best Practices in Drug Naming

Segment 2:
Hassen A. Sayeed, Partner
Ropes & Gray LLP

  • Update some recent decisions on induced infringement aspect
  • Other recent decisions
  • Update state of the law

Segment 3:
Nancy Pei, Partner
Smart & Biggar

  • Trademark and regulatory process for drug names in Canada
  • Data protection and possible future patent term restoration
  • Patented Medicines (Notice of Compliance) Regulations (listing, litigation)

Who Should Attend

  • Pharmaceutical Industry Lawyers
  • Pharmaceutical Company Executives
  • Pharmaceutical Firms
  • Pharmaceutical Developers and Manufacturers
  • Medical Directors
  • Medical Providers
  • Other Related/Interested Professionals and Organizations

Pharmaceutical Brand Protection Program CLE

Segment 1:
Karen Won, Attorney
Cooley LLP

  • Branding basics: Drug Names
  • Overview of the Trademark Process for Drug Names at the USPTO
  • Overview of the Regulatory Process for Drug Names at the FDA
  • Best Practices in Drug Naming

Segment 2:
Hassen A. Sayeed, Partner
Ropes & Gray LLP

  • Update some recent decisions on induced infringement aspect
  • Other recent decisions
  • Update state of the law

Segment 3:
Nancy Pei, Partner
Smart & Biggar

  • Trademark and regulatory process for drug names in Canada
  • Data protection and possible future patent term restoration
  • Patented Medicines (Notice of Compliance) Regulations (listing, litigation)

Pharmaceutical Brand Protection Program CLE

Pharmaceutical Brand Protection Program CLE

Hassen A. SayeedPartnerRopes & Gray LLP

Hassen A. Sayeed, M.D. counsels life sciences clients in all aspects of complex patent litigation to help businesses achieve their strategic goals. Dr. Sayeed has litigated a diverse variety of technologies, including pharmaceuticals, biotechnology, and medical devices. He also has extensive experience with cases arising under the Hatch-Waxman Act on behalf of pioneer pharmaceutical companies.

Pharmaceutical Brand Protection Program CLE

Karen WonAttorneyCooley LLP

Karen is an attorney in the Trademark, Copyright and Advertising group at Cooley LLP. Her practice mostly focuses on trademark and copyright issues but also includes advertising, right of publicity, domain names and other related areas.  Karen advises clients across many sectors but with a particular focus on technology including consumer tech, enterprise tech, life sciences, and bio/med tech.  Karen works with clients on the selection, clearance, adoption, and use of trademarks; domestic and international trademark prosecution and enforcement; trademark portfolio management; development of comprehensive branding strategies; trademark licensing; and due diligence analysis. She also represents clients in federal litigation, proceedings before the Trademark Trial and Appeal Board, and internet domain disputes before the World Intellectual Property Organization and the National Arbitration Forum. Karen is also actively involved in a range of pro bono matters.

Pharmaceutical Brand Protection Program CLE

Nancy PeiPartnerSmart & Biggar

Nancy Pei practises exclusively in the field of life sciences (pharmaceuticals, biologics, medical devices, natural health products). She has over fifteen years of experience with pharmaceutical patent and related litigation and in providing regulatory advice to clients operating in the life sciences industry.

Nancy represents innovative pharmaceutical companies in litigation relating to the Patented Medicines (Notice of Compliance) Regulations and in patent infringement actions. She has represented clients before the Federal Court of Canada, the Federal Court of Appeal, the Supreme Court of Canada, the Ontario Superior Court of Justice, and in opposition proceedings before the Canadian Intellectual Property Office. She also provides advice on matters relating to patent listing, data protection, the Patented Medicine Prices Review Board, and access to information requests. Nancy’s hands-on experience as a pharmacist coupled with the expertise gained through her highly focussed yet diverse practice afford her a unique position in examining broader patenting and regulatory issues of importance to innovative pharmaceutical clients.


Click Here to Read Additional Material

Pharmaceutical Brand Protection Program CLE

Course Level:
   Intermediate

Advance Preparation:
   Print and review course materials

Method Of Presentation:
   On-demand Webcast

Prerequisite:
   NONE

Course Code:
   155334

NASBA Field of Study:
   Specialized Knowledge and Applications

NY Category of CLE Credit:
   Skills

Total Credits:
    2.0 CLE

No Access

You are not logged in. Please or register to the event to gain access to the materials and login instructions.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

When clients come to Ropes & Gray, they find a global team of more than 1,100 professionals, whose top-notch skills, varied backgrounds and unique perspectives can help them meet high-stakes challenges, solve complex problems and reach their goals. An international presence, the firm has offices in New York, Washington, D.C., Boston, Chicago, San Francisco, Silicon Valley, London, Hong Kong, Shanghai, Tokyo and Seoul.

Many of the world’s most respected companies and institutions are longtime clients. The firm serves many organizations (and investors and individuals) at all stages of the business life cycle, from start-ups to establishment as industry leaders.

Ropes & Gray has always focused on providing clients with the highest quality advice on their most critical legal and business needs. Ropes & Gray is a thoroughly contemporary firm that can bring 150 years of legal and institutional history to bear on the challenges clients face in today’s global, networked, 24/7 environment. A collaborative approach means that clients have ready access to leading corporate, litigation, transactional and regulatory lawyers whose knowledge and experience span industries and geographies.

Website: https://www.ropesgray.com/

Cooley’s attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law. Cooley has 850 lawyers across 12 offices in the United States, China and Europe. The firm’s Trademark, Copyright and Advertising practice is one of the largest of any of the AmLaw 50 law firms, with 23 lawyers, including 7 partners, and 10 paralegals. Year after year, Cooley is recognized as one of the top full service trademark practices in the United States by several legal directories including Chambers, Legal 500, Managing Intellectual Property, and World Trademark Review. Our clients range from trailblazing start-ups to Fortune 500 companies, all of which benefit from our unique, business-focused approach to developing trademark and brand-building strategies tailored to each client’s definition of success.

Website: https://cooley.com/

Smart & Biggar is Canada's largest and highest-ranked firm practising exclusively in intellectual property and technology law, with offices in Ottawa, Toronto, Montreal, Vancouver and Calgary. Related to Fetherstonhaugh - Canada's largest patent agency firm - through common partners, offices and personnel, we have been leaders in intellectual property and technology law for over a century.  Our experience is unmatched and our goal is unwavering: to provide our clients with UNPARALLELED IP.

Website: https://www.smart-biggar.ca/en/index.cfm

Hassen A. Sayeed, M.D. counsels life sciences clients in all aspects of complex patent litigation to help businesses achieve their strategic goals. Dr. Sayeed has litigated a diverse variety of technologies, including pharmaceuticals, biotechnology, and medical devices. He also has extensive experience with cases arising under the Hatch-Waxman Act on behalf of pioneer pharmaceutical companies.

Karen is an attorney in the Trademark, Copyright and Advertising group at Cooley LLP. Her practice mostly focuses on trademark and copyright issues but also includes advertising, right of publicity, domain names and other related areas.  Karen advises clients across many sectors but with a particular focus on technology including consumer tech, enterprise tech, life sciences, and bio/med tech.  Karen works with clients on the selection, clearance, adoption, and use of trademarks; domestic and international trademark prosecution and enforcement; trademark portfolio management; development of comprehensive branding strategies; trademark licensing; and due diligence analysis. She also represents clients in federal litigation, proceedings before the Trademark Trial and Appeal Board, and internet domain disputes before the World Intellectual Property Organization and the National Arbitration Forum. Karen is also actively involved in a range of pro bono matters.

Nancy Pei practises exclusively in the field of life sciences (pharmaceuticals, biologics, medical devices, natural health products). She has over fifteen years of experience with pharmaceutical patent and related litigation and in providing regulatory advice to clients operating in the life sciences industry.

Nancy represents innovative pharmaceutical companies in litigation relating to the Patented Medicines (Notice of Compliance) Regulations and in patent infringement actions. She has represented clients before the Federal Court of Canada, the Federal Court of Appeal, the Supreme Court of Canada, the Ontario Superior Court of Justice, and in opposition proceedings before the Canadian Intellectual Property Office. She also provides advice on matters relating to patent listing, data protection, the Patented Medicine Prices Review Board, and access to information requests. Nancy’s hands-on experience as a pharmacist coupled with the expertise gained through her highly focussed yet diverse practice afford her a unique position in examining broader patenting and regulatory issues of importance to innovative pharmaceutical clients.

Ultimate Value Annual Program

Bring a colleague for only $149, a savings of $50 per additional attendee.

  • Unlimited Access to Live & Recorded Webcasts
  • Instant Access to Course Materials
  • And More!

$199